A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153)

NCT00546286 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma
Ocular Hypertension

Interventions

DRUG: dorzolamide hydrochloride (+) timolol maleate
DRUG: Comparator: dorzolamide HCl/timolol maleate + prostaglandin

Sponsor

Merck Sharp & Dohme LLC